BRANDED INJECTABLE CEPHALOSPORINES
Lupin acquires UK-based firm for 12.3 million poundsLupin has acquired UK-based Renascience Pharma for £12.3 million, enhancing its branded medicine portfolio. The acquisition allows Lupin to...
For investors with risk appetite: 4 smallcap stocks with upside potential of up to 36%The risk on trade, which essentially means taking exposure to the riskier asset class started once again. In India, this meant that once ag...- Sharekhan sees 30% upside in LupinSharekhan has maintained a Buy recommendation on pharmaceutical major Lupin.
- Pharma cos inject capacities to meet growing demandIndian pharmaceutical companies with a presence in sterile injectables space are expanding capacities to cater to growing demand in this se...
- Pfizer to license generics from India's AurobindoPfizer Inc has agreed to license an array of generic pills and injectable medicines from India's Aurobindo Pharma Ltd as the world's larges...
- Wockhardt gets USFDA approval for Ceftazidime injectionCeftazidime is the generic name for the brand Fortaz, sold in the US by Glaxo Smithkline.
Load More- Pharma cos inject capacities to meet growing demand